SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Preventive Visit — Madam C. J. Walker

PatientSarah Walker
Date of birth1976-12-23
IdentifiersMRN HR-ET019-SYN; SSN (made up) 000-19-7062
Document date2026-06-08
AuthorHarriet Okonjo-Bell, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit. [S]

History of Present Illness

Madam Walker is a 49-year-old company founder with hypertension and chronic kidney disease G3a A2 who comes for her yearly preventive visit six weeks after her eleven-week review. Amlodipine was added then, and her home readings now average 127/80. She has had no ankle swelling, dizziness or genital itching. She restarted losartan and empagliflozin after the stomach illness two months ago and has had no further trouble. She has been on the road three weeks out of four, sleeping six hours on travel nights. She is using the salt-free seasoning at home and asking for sauces on the side at banquets. She wants to know which screening tests she needs and when, so that she can fit them between trips. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 49
Home blood pressureAverage 127/80 on losartan 100 mg and amlodipine 5 mg
TravelThree weeks in four
MoodPHQ-2 0

Health risk assessment. Completed on the patient portal before the visit and reviewed with her by Dr. Okonjo-Bell. [S]

DomainFinding
Self-rated healthGood
PsychosocialBusy and purposeful; stress from the pace of work, which she manages and does not want to give up
Substance useNo tobacco or drugs; a glass of wine at some events (AUDIT-C 1)
Physical activityWalks during layovers and on home mornings, about 120 minutes a week
NutritionSalt-free seasoning at home; sauces on the side and no added salt on the road; water in place of a third coffee
SleepSix hours on travel nights, seven at home
Food and housingSecure
SafetySeat belt always; feels safe at home
Health care experiencesWants the numbers and the reasons; satisfied that her plan fits her work
Activities of daily livingIndependent

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or weight change; weight down 2.4 kg since intake
EyesNegativeNo change in vision
Ears, nose, mouth, and throatNegativeNo hoarseness
CardiovascularNegativeNo chest pain, palpitations or ankle swelling
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeStomach illness resolved; no blood in the stool
GenitourinaryNegativeNo burning, itching or discharge; periods becoming irregular
BreastNegativeNo lump, skin change or nipple discharge
MusculoskeletalNegativeNo joint pain
IntegumentaryNegativeNo changing moles; no scalp or hair problems
NeurologicalNegativeNo headaches since her blood pressure came down
PsychiatricNegativeMood steady; PHQ-2 0

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Losartan 50 mg oral tablet, one tablet each morningOne tablet each morning, at the same home time when travelingOral route2026-02-23 to 2026-03-09completedS
Losartan 100 mg oral tablet, one tablet each morningOne tablet each morningOral route2026-03-09activeS
Empagliflozin 10 mg oral tablet, one tablet each morning; stop on days of vomiting, diarrhea or not eating, and before surgeryOne tablet each morning, with sick-day rulesOral route2026-02-23activeS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-02-23activeS
Ondansetron 4 mg orally disintegrating tablet, one tablet on the tongue every 8 hours as needed for nausea, for up to two daysEvery 8 hours as needed for nausea, up to two daysOral route2026-04-13 to 2026-04-15completedS
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-04-27activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-08Body height163cmS
2026-06-08Body weight76.6kgS
2026-06-08Body mass index (BMI) [Ratio]28.8kg/m2S
2026-06-08Systolic blood pressure126mm[Hg]S
2026-06-08Diastolic blood pressure80mm[Hg]S
2026-06-08Heart rate74/minS
2026-06-08Respiratory rate16/minS
2026-06-08Body temperature36.7CelS
2026-06-08Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-08Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-06-08Total score [AUDIT-C]1{score}S

Physical Exam

Vital signs recorded on 2026-06-08; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; weight 76.6 kg, BMI 28.8; blood pressure 126/80
EyesVisual acuity 20/20 in each eye with reading glasses for near
MouthTeeth and gums healthy
NeckNo thyroid enlargement
CardiovascularRegular rhythm; no murmur; no ankle swelling
RespiratoryClear
BreastExamined with a female chaperone and her agreement: no masses, skin changes or nipple discharge
AbdomenSoft, non-tender
SkinNo suspicious lesions
PsychiatricEngaged and direct

Problems

ProblemClinical statusVerificationCodeProvenance
Elevated blood pressure at intake (166/102 mmHg, average of two readings), first found at a workplace screening; ambulatory monitoring to confirmresolvedconfirmed R03.0S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks.
Albumin in the urine (urine albumin-to-creatinine ratio 286 mg/g) with eGFR 54 by the race-free CKD-EPI 2021 equation; she recalls protein in the urine at an executive physical a year ago, and those records are requested; to be repeated and investigatedresolvedconfirmed R80.9S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks.
Hypertension, stage 2, confirmed by 24-hour ambulatory monitoring (24-hour mean 149/94, daytime 154/98, night 140/88 without the normal nighttime fall), with left ventricular hypertrophy on ECG and mild hypertensive retinopathy; synthetic modern episode linked to her documented high blood pressureactiveconfirmed I12.9S — Synthetic modern diagnosis anchored to the documented hypertension and nephritis.
Chronic kidney disease G3a A2 (eGFR 54 to 55 mL/min/1.73 m2 by the race-free CKD-EPI 2021 equation; albumin-to-creatinine ratio 286 to 294 mg/g; present for more than three months), most likely hypertensive kidney disease; bland urine sediment and normal-sized kidneys on ultrasound; 5-year kidney failure risk 1.6%activeconfirmed N18.31S — Synthetic kidney findings anchored to the documented nephritis and death from kidney disease.
Hyperlipidemia: LDL 174 mg/dL; 10-year ASCVD risk 7.9% by the Pooled Cohort Equations (intermediate)activeconfirmed E78.5S — Synthetic laboratory finding.
Viral gastroenteritis after a sales convention, with mild volume depletion and losartan and empagliflozin held under her sick-day rules; no acute kidney injury; resolvedresolvedconfirmed A08.4S — Synthetic intercurrent illness; not a historical claim.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressureCompleted today126/80 mmHg; home average 127/80
Depression screeningCompleted todayPHQ-2 score 0
Unhealthy alcohol use screeningCompleted todayAUDIT-C 1
Tobacco useCompleted todayNever
Breast cancer screeningOrderedMammogram every two years from 40; booked in two weeks on a day she is home
Cervical cancer screeningCompleted todayPrimary HPV test every five years from 30, her choice
Colorectal cancer screeningOrderedFrom 45; stool immunochemical test yearly, her choice so that she can mail it while traveling; colonoscopy discussed
HIV screeningUp to dateNegative with the kidney evaluation in February
Hepatitis C screeningUp to dateNegative with the kidney evaluation in February
Hepatitis B screeningUp to dateSurface antigen negative, no immunity, in February; vaccination started today
Diabetes screeningUp to dateA1c 5.4% at intake
Statin for preventionUp to dateAtorvastatin 20 mg since February; LDL 98 mg/dL
Healthy diet and physical activity counselingCompleted todaySodium plan with the dietitian; walking during layovers
Pneumococcal vaccineCompleted todayPCV20 for chronic kidney disease
TdapCompleted todayNo booster within ten years
Hepatitis B vaccineCompleted todayDose 1 of 2 (HepB-CpG)
Recombinant zoster vaccineDueFrom 50, after her birthday
Influenza and COVID-19 vaccinesDueInfluenza given in February; both due in the autumn
Eye examinationDueMild hypertensive retinopathy at intake; dilated examination by an optometrist yearly
Osteoporosis screeningNot indicatedNot yet postmenopausal and no risk factors that call for earlier screening

Immunizations given today: Pneumococcal conjugate vaccine PCV20; Tetanus, diphtheria, and acellular pertussis vaccine (Tdap); Hepatitis B vaccine (HepB-CpG), dose 1 of 2 [S]

Guideline basis: Adult Immunization Schedule by Age (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Breast Cancer: Screening (2024); Cervical Cancer: Screening (2018); Colorectal Cancer: Screening (2021); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018); Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations, United States, 2023 (2023)

Follow-up: Mammogram in two weeks; stool test by mail; HPV result by the portal. Six-month review in ten weeks with urine albumin, kidney function, hemoglobin, the PHQ-9 and the second hepatitis B dose. Next preventive visit in one year. Next scheduled visit 2026-08-17: six-month review: blood pressure at goal, urine albumin, kidney function, hemoglobin, mood, and the travel season ahead. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She wants full treatment of any illness that could be reversed, including dialysis if her kidneys ever failed, and wants to be told plainly what is happening at every stage. She has named a health care agent, recorded in the confidential part of the chart and not named here, and has a will and business succession plan in place through her company. She chose not to record other treatment preferences today. To be revisited yearly or after any serious illness. [S]